Drug maker Strides Arcolab has reported a massive
growth of 48.8% year-on-year in its profit after tax of Rs 61 crore in the
fourth quarter of FY12. Its PAT stood at Rs 41 crore in a year ago period.
Revenues increased 40.22% to Rs 495 crore from Rs 353 crore
year-on-year.
Earnings before interest, tax, depreciation and amortisation
(EBITDA) jumped 65% to Rs 137 crore in the January-March quarter of 2011 versus
Rs 83 crore in the corresponding quarter of last fiscal.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment